C-Suite Snippets: Behind The Scenes At Gates Medical Research Institute
In case you missed it: catch up with snippets from interviews recently published by In Vivo.
You may also be interested in...
In Vivo visits Gates Medical Research Institute CEO Dr. Penny Heaton to review its first pipeline of drugs and vaccines to attack four of the world’s biggest killers: TB, malaria, enteric diseases and other conditions affecting maternal, newborn and child health.
Lyon, France-based Novadiscovery is developing a user-facing technology to run in silico studies, a method it expects to cut development costs and improve trial success rates. But acceptance of “new” data types is often a concern for drug developers, despite world-leading regulatory bodies stating their desire for 21st century approaches.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.